Clinical trial
Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients…
NCT00453050 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00453050 |
|---|---|
| Title | Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin |
| Official title | Laser and TLR-Agonist Immunotherapy: A Novel Autologous Melanoma Vaccine Study |
| Lead sponsor | University of Oklahoma, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin), Metastatic Cancer |
| Intervention type | Drug, Other |
| Interventions | imiquimod, indocyanine green solution, flow cytometry, immunologic technique, laboratory biomarker analysis |
| Enrollment | 11 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2009 |
| First posted | Mar 28, 2007 |
| Last update posted | May 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: